Related references
Note: Only part of the references are listed.Reductions in overactive bladder-related incontinence from pooled analysis of phase III trials evaluating treatment with solifenacin
Linda Cardozo et al.
INTERNATIONAL UROGYNECOLOGY JOURNAL (2006)
An epidemiological survey of overactive bladder symptoms in Japan
Y Homma et al.
BJU INTERNATIONAL (2005)
The effects of antimuscarinic treatments in overactive bladder: A systematic review and meta-analysis
C Chapple et al.
EUROPEAN UROLOGY (2005)
Antimuscarinics for treatment of overactive bladder
KE Andersson
LANCET NEUROLOGY (2004)
Prospective, randomized, double-blind study of the efficacy and tolerability of the extended-release formulations of oxybutynin and tolterodine for overactive bladder: Results of the OPERA trial
AC Diokno et al.
MAYO CLINIC PROCEEDINGS (2003)
Clinical efficacy and tolerability of extended-release tolterodine and immediate-release oxybutynin in Japanese and Korean patients with an overactive bladder: a randomized, placebo-controlled trial
Y Homma et al.
BJU INTERNATIONAL (2003)
Pharmacological effects of KRP-197 on the human isolated urinary bladder
S Murakami et al.
UROLOGIA INTERNATIONALIS (2003)
How widespread are the symptoms of an overactive bladder and how are they managed?: A population-based prevalence study
I Milsom et al.
BJU INTERNATIONAL (2001)
Share Paper
